Immunotherapeutic targets in estrogen deficiency-dependent Sjgrens syndrome-related manifestations

Immunotherapy

Volumn 2, Issue 3, 2010, Pages 339-346

  Arakaki, Rieko ^a   Ishimaru, Naozumi ^a   Hayashi, Yoshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Animal model; Apoptosis; Autoimmune exocrinopathy; Estrogen deficiency; RbAp48; Sj gren's syndrome; Transgenic mice

Indexed keywords

FODRIN; PROTEIN P53; RETINOBLASTOMA ASSOCIATED PROTEIN 48; RETINOBLASTOMA PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE EXOCRINOPATHY; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; ESTROGEN DEFICIENCY; EXOCRINE GLAND; HUMAN; IMMUNOTHERAPY; NONHUMAN; OVARIECTOMY; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SJOEGREN SYNDROME;

ANIMALS; APOPTOSIS; ESTROGENS; FEMALE; HUMANS; IMMUNOTHERAPY; MICE; MICE, TRANSGENIC; RETINOBLASTOMA-BINDING PROTEIN 4; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 77953393154     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/imt.10.18     Document Type: Review

References (51)

1. Whitacre CC: Sex differences in autoimmune disease. Nat. Immunol. 2, 777-780 (2001).
2. Whitacre CC, Reingold SC, O'Looney PA: A gender gap in autoimmunity. Science 283, 277-1278 (1999).
3. Apostolou I, Hao Z, Rajewsky K, von Boehmer H: Effective destruction of Fas-deficient insulin-producing bcells in Type 1 diabetes. J. Exp. Med. 198, 1103-1106 (2003).
4. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A: Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J. Exp. Med. 198, 1119-1126 (2003).
5. Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH: Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/-mice. Nat. Immunol. 4, 255-260 (2003).
6. Rathmell JC, Thompson CB: Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109, S97-S107 (2002).
7. Stassi G, De Maria R: Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat. Rev. Immunol. 2, 195-204 (2002).
8. Ishimaru N, Saegusa K, Yanagi K, Haneji N, Saito I, Hayashi Y: Estrogen dediciency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis. Am. J. Pathol. 155, 173-181 (1999).
9. Ishimaru N, Arakaki R, Watanabe M, Kobayashi M, Miyazaki K, Hayashi Y: Development of autoimmune exocrinopathy resembling Sjogren's syndrome in estrogen deficient mice of healthy background. Am. J. Pathol. 163, 1481-1490 (2003). (Pubitemid 37175095)
10. Kyprianou N, English HF, Davidson NE, Isaacs JT: Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51, 162-166 (1991).
11. Hugues S, Mougneau E, Ferlin W et al.: Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic bcells. Immunity 16, 169-181 (2002).
12. Petrovsky N, Silva D, Socha L, Slattery R, Charlton B: The role of Fas ligand in bcell destruction in autoimmune diabetes of NOD mice. Ann. NY Acad. Sci. 958, 204-208 (2002).
13. Ruuls SR, Hoek RM, Ngo VN et al.: Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15, 533-543 (2001).
14. Christen U, Von Herrath MG: Apoptosis of autoreactive CD8 lymphocytes as a potential mechanism for the abrogation of Type 1 diabetes by islet-specific TNF-a expression at a time when the autoimmune process is already ongoing. Ann. NY Acad. Sci. 958, 166-169 (2002).
15. Zhang Y, O'Brien B, Trudeau J, Tan R, Santamaria P, Dutz JP: In situ bcell death promotes priming of diabetogenic CD8 T lymphocytes. J. Immunol. 168, 1466-1472 (2002).
16. Ishimaru N, Arakaki R, Omotehara F et al.: Novel role of RbAp48 for tissue-specific estrogen deficiency-dependent apoptosis in the exocrine glands. Mol. Cell. Biol. 26, 2924-2935 (2006).
17. Hiebert SW: Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13, 3384-3391 (1993).
18. Lieman JH, Worley LA, Harbour JW: Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase. J. Biol. Chem. 280, 10484-10490 (2005).
19. Haneji N, Nakamura T, K. Takio K et al.: Identification of a-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 276, 604-607 (1997).
20. Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF: E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol. Cell Biol. 22, 5308-5318 (2002).
21. Vousden KH: p53: death star. Cell 103, 691-694 (2000).
22. Ding HF, Lin YL, McGill G et al.: Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J. Biol. Chem. 275, 38905-38911 (2000).
23. Oren M: Decision making by p53: life, death and cancer. Cell Death Differ. 10, 431-442 (2003).
24. Saito I, Haruta K, Shimuta M et al.: Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10. J. Immunol. 162, 2488-2494 (1999).
25. Ishimaru N, Arakaki R, Yoshida S, Yamada A, Noji S, Hayashi Y: Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy. J. Exp. Med. 205, 2915-2927 (2008).
26. Qian YW, Wang YC, Hollingsworth RE Jr, Jones D, Ling N, Lee EY: A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature 364, 648-652 (1993).
27. Nicolas E, Ait-Si-Ali S, Trouche D: The histone deacetylase HDAC3 targets RbAp48 to the retinoblastoma protein. Nucleic Acids Res. 29, 3131-3136 (2001).
28. Lai A, Lee JM, Yang WM et al.: RBP1 recruits both histone deacetylase-dependent and-independent repression activities to retinoblastoma family proteins. Mol. Cell. Biol. 19, 6632-6641 (1999).
29. Nicolas E, Morales V, Magnaghi-Jaulin L, Harel-Bellan A, Richard-Foy H, Trouche D: RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein. J. Biol. Chem. 275, 9797-9804 (2000).
30. Wang RH, Liu CW, Avramis VL, Berndt N: Protein phosphatase 1a-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene 20, 6111-6122 (2001).
31. Dou QP, An B, Will PL: Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc. Natl Acad. Sci. USA 92, 9019-9023 (1995).
32. Murga M, O. Fernandez-Capetillo O, Field SJ et al.: Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15, 959-970 (2001).
33. Field SJ, F. Tsai Y, Kuo F et al.: E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549-561 (1996).
34. Nicolas E, Morales V, Magnaghi-Jaulin L et al.: RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein. J. Biol. Chem. 275, 9797-9804 (2000).
35. Szende B, Romics I, Vass L: Apoptosis in prostate cancer after hormonal treatment. Lancet 342, 1422 (1993).
36. Spyridopoulos I, Sullivan A, Kearney M, Isner J, Losordo D: Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 95, 1505-1514 (1997).
37. Pelzer T, Schumann M, Neumann M et al.: 17b-estradiol prevents programmed cell death in cardiac myocytes. Biochem. Biophys. Res. Commun. 268, 192-200 (2000).
38. Pike CJ: Estrogen modulates neuronal Bcl-xL expression and b-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72, 1552-1563 (1999).
39. Janicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357-9360 (1998)
40. Cryns VL, Bergeron L, Zhu H, Li H, Yuan J: Specific cleavage of a-fodrin during Fas-and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1b-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J. Biol. Chem. 271, 31277-31282 (1996).
41. Wang KK, Posmantur R, R. Nath R et al.: Simultaneous degradation of aII-and bII-spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem. 273, 22490-22497 (1998).
42. Acarturk F, Robinson JR: Vaginal permeability and enzymatic activity studies in normal and ovariectomized rabbits. Pharm. Res. 13, 779-783 (1996).
43. Oner P, Bekpinar S, Cinar F, Argun A: Relationship of some endogenous sex steroid hormones to leukocyte arylsulphatase A activities in pre-and postmenopausal healthy women. Horm. Metab. Res. 26, 301-304 (1994).
44. Katsuda K, Kataoka M, Uno F et al.: Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells. Oncogene 21, 2108-2113 (2002).
45. Tan X, Wang JYJ: The caspase-RB connection in cell death. Trends Cell Biol. 8, 116-120 (1998).
46. Vanags DM, Porn-Ares MI, Coppola S, Burgess DH, Orrenius S: Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271, 31075-31085 (1996). (Pubitemid 26408546)
47. Gdula DA, Sandaltzopoulos R, Tsukiyama T, Ossipow V, Wu C: Inorganic pyrophosphatase is a component of the Drosophila nucleosome remodeling factor complex. Genes Dev. 12, 3206-3216 (1998).
48. Davidson A, Diamond B: Autoimmune diseases. N. Engl. J Med. 345, 340-350 (2001).
49. Marrack P, Kappler J, Kotzin BL: Autoimmune disease: why and where it occurs. Nat. Med. 7, 899-905 (2001).
50. Ishimaru N, Takagi A, Kohashi M et al.: Neonatal exposure to low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin causes autoimmunity due to the disruption of T cell tolerance. J. Immunol. 182, 6576-6586 (2009).
51. Shim GJ, Warner M, Kim HJ et al.: Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc. Natl Acad. Sci. USA 101, 12628-12633 (2004).